| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.36 | 6e-27 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-14 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-13 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-10 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-10 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-09 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-09 |